TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,148 | +37.9% | 10,765 | -8.2% | 0.00% | – |
| Q4 2022 | $11,707 | -83.7% | 11,721 | -70.6% | 0.00% | – |
| Q3 2022 | $72,000 | -70.2% | 39,914 | -52.2% | 0.00% | – |
| Q2 2022 | $242,000 | -48.1% | 83,466 | -50.6% | 0.00% | – |
| Q1 2022 | $466,000 | -70.8% | 168,799 | -50.8% | 0.00% | – |
| Q4 2021 | $1,597,000 | +134.9% | 342,764 | +329.2% | 0.00% | – |
| Q3 2021 | $680,000 | -87.8% | 79,867 | -76.4% | 0.00% | -100.0% |
| Q2 2021 | $5,560,000 | -37.0% | 338,737 | -15.2% | 0.00% | -50.0% |
| Q1 2021 | $8,822,000 | +15.0% | 399,518 | +61.1% | 0.00% | 0.0% |
| Q4 2020 | $7,671,000 | +697.4% | 248,018 | +423.8% | 0.00% | – |
| Q3 2020 | $962,000 | +275.8% | 47,352 | +184.1% | 0.00% | – |
| Q2 2020 | $256,000 | -74.0% | 16,668 | -70.5% | 0.00% | – |
| Q1 2019 | $984,000 | – | 56,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 3,370,982 | $68,498,000 | 16.50% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $82,314,000 | 15.35% |
| Consonance Capital Management LP | 1,509,819 | $30,680,000 | 3.74% |
| Soleus Capital Management, L.P. | 282,041 | $5,731,000 | 3.04% |
| Redmile Group, LLC | 2,793,288 | $56,760,000 | 1.04% |
| PFM Health Sciences, LP | 775,794 | $15,764,000 | 0.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,200,000 | $24,384,000 | 0.59% |
| Cormorant Asset Management, LP | 600,000 | $12,192,000 | 0.47% |
| Sofinnova Investments, Inc. | 173,028 | $3,516,000 | 0.26% |
| Artal Group S.A. | 500,000 | $10,160,000 | 0.25% |